Choose a section
Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.
A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.
Mylan has settled a patent-infringement lawsuit filed by Shionogi over its generic version of a drug for diabetes, Mylan said.
It seems that Fluffy is getting a little fluffy as a new survey indicates that pet obesity is on the rise, particularly among cats.
Drug maker Merck has hired celebrity chef and cookbook author Leticia Moreinos Schwartz as a spokeswoman to reach out to Hispanics living with Type 2 diabetes, the drug maker said.
The cost of diabetes has increased by more than $70 billion over the past five years, according to new research from the American Diabetes Association.
Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.
The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.
Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.
The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.